source
- Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory footholdAt PepMed 2026, a conference focused on peptide medicines, stem cell entrepreneur Chuck Meeker said he expects the FDA to hold a series of roundtables on regenerative therapies before year‑end. He…
- Swiss CDMOs and CROs experience rapid growth as global sponsors seek specialized manufacturing and decentralized trialsSwitzerland’s contract development and manufacturing organisations (CDMOs) and contract research organisations (CROs) are entering a new boom cycle, driven by rising global demand for specialised m…